Search Results - "Gaffar, Yousuf"

Phase 3b UPFRONT Study: Safety and Efficacy of Weekly Bortezomib Maintenance Therapy After Bortezomib-Based Induction Regimens In Elderly, Newly Diagnosed Multiple Myeloma Patients by Niesvizky, Ruben, Flinn, Ian W., Rifkin, Robert M., Gabrail, Nashat Y, Charu, Veena, Clowney, Billy, Essell, James, Gaffar, Yousuf A, Warr, Thomas A., Neuwirth, Rachel, Corzo, Deyanira, Reeves, James A

“…Abstract 619 The UPFRONT study is a US community-based, randomized, open-label, multicenter phase 3b trial comparing the safety and efficacy of three…”
Get full text

Community-Based Phase IIIB Trial of Three UPFRONT Bortezomib-Based Myeloma Regimens by Niesvizky, Ruben, Flinn, Ian W, Rifkin, Robert, Gabrail, Nashat, Charu, Veena, Clowney, Billy, Essell, James, Gaffar, Yousuf, Warr, Thomas, Neuwirth, Rachel, Zhu, Yanyan, Elliott, Jennifer, Esseltine, Dixie-Lee, Niculescu, Liviu, Reeves, James

“…The US community-based, phase IIIB UPFRONT trial was designed to compare three frontline bortezomib-based regimens in transplantation-ineligible patients with…”
Get full text

Efficacy and Safety Of Three Bortezomib-Based Induction and Maintenance Regimens In Previously Untreated, Transplant-Ineligible Multiple Myeloma (MM) Patients (Pts): Final Results From The Randomized, Phase 3b, US Community-Based UPFRONT Study (NCT00507416) by Niesvizky, Ruben, Flinn, Ian, Rifkin, Robert M., Essell, James, Gaffar, Yousuf, Warr, Thomas, Neuwirth, Rachel, Ba-Mancini, Abbie, Zhu, Yanyan, Niculescu, Liviu, Reeves, James

“…The UPFRONT trial compared the efficacy and safety of three bortezomib (V)-based induction regimens – VD (V-dexamethasone), VTD (V-thalidomide-dexamethasone),…”
Get full text

Patient-Reported Quality of Life (QoL) in Elderly, Newly Diagnosed Multiple Myeloma (MM) Patients Receiving Bortezomib-Based Combinations: Results From All Randomized Patients in the Community-Based, Phase 3b UPFRONT Study by Niesvizky, Ruben, Flinn, Ian W., Rifkin, Robert, Gabrail, Nashat, Charu, Veena, Clowney, Billy, Gaffar, Yousuf, Warr, Thomas A., Neuwirth, Rachel, Huang, Hui, Choi, Sanggyu, Corzo, Deyanira

“…Abstract 1864 In addition to determining the efficacy and safety of different treatment options for MM, the impact of treatment and associated toxicities on…”
Get full text

Efficacy and Safety of Three Bortezomib-Based Combinations in Elderly, Newly Diagnosed Multiple Myeloma Patients: Results From All Randomized Patients in the Community-Based, Phase 3b UPFRONT Study by Niesvizky, Ruben, Flinn, Ian W., Rifkin, Robert, Gabrail, Nashat, Charu, Veena, Clowney, Billy, Essell, James, Gaffar, Yousuf, Warr, Thomas A., Neuwirth, Rachel, Corzo, Deyanira, Reeves, James

“…Abstract 478 The US community-based, phase 3b randomized, open-label, multicenter UPFRONT trial compares the efficacy and safety of three bortezomib (VELCADE®,…”
Get full text

Patient-Reported Quality of Life In Elderly, Newly Diagnosed Multiple Myeloma Patients Treated with Bortezomib-Based Regimens: Results From the Phase 3b UPFRONT Study by Niesvizky, Ruben, Flinn, Ian W., Rifkin, Robert M., Gabrail, Nashat Y, Charu, Veena, Clowney, Billy, Essell, James, Gaffar, Yousuf A, Warr, Thomas A., Neuwirth, Rachel, Corzo, Deyanira, Reeves, James A

“…Abstract 3026 UPFRONT is an ongoing US community-based phase 3b study designed to compare the safety and efficacy of three bortezomib (Velcade®, Vc)-based…”
Get full text